SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-20-014783
Filing Date
2020-07-07
Accepted
2020-07-07 16:20:22
Documents
8
Effectiveness Date
2020-07-07

Document Format Files

Seq Description Document Type Size
1 FORM S-8 vxrt20200701_s8.htm S-8 87278
2 EXHIBIT 5.1 ex_192634.htm EX-5.1 7547
3 EXHIBIT 10.1 ex_192635.htm EX-10.1 154300
4 EXHIBIT 10.2 ex_192636.htm EX-10.2 101139
5 EXHIBIT 23.2 ex_192637.htm EX-23.2 3023
6 EXHIBIT 23.3 ex_192638.htm EX-23.3 3337
7 ex_192634img001.jpg GRAPHIC 8181
8 ex_192634img002.jpg GRAPHIC 7820
  Complete submission text file 0001437749-20-014783.txt   380257
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-239727 | Film No.: 201016278
SIC: 2836 Biological Products, (No Diagnostic Substances)